Effect of a platelet-activating factor antagonist, E5880, on cerebrovasospasm following subarachnoid hemorrhage in a canine double-hemorrhage model

By Abe Y.   Kasuya H.   Suzuki S.   Yamanishi Y.   Hori T.  

European Journal of Pharmacology, Vol. 455, Iss. 2, 2002-11 ,pp. : 127-133

Elsevier

Access to resources Recommend Favorite

Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist

By Albert D.H.   Magoc T.J.   Tapang P.   Luo G.   Morgan D.W.   Curtin M.   Sheppard G.S.   Xu L.   Heyman H.R.   Davidsen S.K.   Summers J.B.   Carter G.W.  

European Journal of Pharmacology, Vol. 325, Iss. 1, 1997-04 ,pp. : 69-80

Elsevier

Access to resources Recommend Favorite

Mechanisms of desensitization of vasodilatation induced by platelet-activating factor in hypertensive rats

By Kamata K.   Numazawa T.   Kasuya Y.  

European Journal of Pharmacology, Vol. 301, Iss. 1, 1996-04 ,pp. : 121-128

Elsevier

Access to resources Recommend Favorite

Inhibitory effect of arachidonic acid on platelet-activating factor production in rat neutrophils

By Naraba H.   Ueno A.   Matsumoto H.   Oh-ishi S.  

European Journal of Pharmacology, Vol. 302, Iss. 1, 1996-04 ,pp. : 117-121

Elsevier

Access to resources Recommend Favorite

Platelet-activating factor receptor antagonist attenuates endotoxin-induced vascular hyporeactivity in the pithed rat

By Yoshikawa D.   Shiga T.   Saito S.   Morita T.   Imai T.   Goto F.  

European Journal of Pharmacology, Vol. 342, Iss. 2, 1998-01 ,pp. : 241-245

Elsevier

Access to resources Recommend Favorite